Michael Burdon

2.8k total citations · 1 hit paper
42 papers, 1.8k citations indexed

About

Michael Burdon is a scholar working on Ophthalmology, Neurology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael Burdon has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Ophthalmology, 17 papers in Neurology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael Burdon's work include Cerebral Venous Sinus Thrombosis (15 papers), Glaucoma and retinal disorders (10 papers) and Pituitary Gland Disorders and Treatments (6 papers). Michael Burdon is often cited by papers focused on Cerebral Venous Sinus Thrombosis (15 papers), Glaucoma and retinal disorders (10 papers) and Pituitary Gland Disorders and Treatments (6 papers). Michael Burdon collaborates with scholars based in United Kingdom, Russia and France. Michael Burdon's co-authors include Alexandra J. Sinclair, Saaeha Rauz, Carl E Clarke, Peter Nightingale, Paul M. Stewart, A S Jacks, Susan P. Mollan, Jeremy Tomlinson, Mark Lawden and Elizabeth A. Walker and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Neurology and Ophthalmology.

In The Last Decade

Michael Burdon

40 papers receiving 1.8k citations

Hit Papers

Idiopathic intracranial hypertension: consensus guideline... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Burdon United Kingdom 21 1.2k 737 232 176 173 42 1.8k
William T. Shults United States 22 897 0.7× 881 1.2× 67 0.3× 871 4.9× 202 1.2× 36 2.0k
Ju‐Hong Min South Korea 18 702 0.6× 117 0.2× 30 0.1× 740 4.2× 161 0.9× 103 1.2k
K. A. Miszkiel United Kingdom 17 580 0.5× 90 0.1× 42 0.2× 466 2.6× 99 0.6× 22 1.1k
Noble J. David United States 16 300 0.2× 152 0.2× 58 0.3× 110 0.6× 99 0.6× 34 823
Ernestina Santos Portugal 19 380 0.3× 83 0.1× 48 0.2× 455 2.6× 115 0.7× 86 1.3k
Ingrid Norheim Sweden 24 781 0.6× 63 0.1× 333 1.4× 57 0.3× 296 1.7× 40 1.7k
Richard P. Mills United States 21 164 0.1× 1.2k 1.6× 57 0.2× 206 1.2× 65 0.4× 62 1.5k
Luigi Bartalena Italy 18 158 0.1× 251 0.3× 727 3.1× 592 3.4× 107 0.6× 42 1.2k
Jack R. Wall Canada 35 486 0.4× 471 0.6× 2.2k 9.4× 1.8k 10.0× 352 2.0× 175 3.5k
Dimitri Renard France 18 519 0.4× 34 0.0× 64 0.3× 114 0.6× 238 1.4× 147 1.1k

Countries citing papers authored by Michael Burdon

Since Specialization
Citations

This map shows the geographic impact of Michael Burdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Burdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Burdon more than expected).

Fields of papers citing papers by Michael Burdon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Burdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Burdon. The network helps show where Michael Burdon may publish in the future.

Co-authorship network of co-authors of Michael Burdon

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Burdon. A scholar is included among the top collaborators of Michael Burdon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Burdon. Michael Burdon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burgess, Philip I., Christiana Dinah, Noemi Lois, & Michael Burdon. (2025). NICE guidelines reaffirm the key role of laser for treating proliferative diabetic retinopathy and diabetic macular oedema. Eye. 40(1). 3–6.
2.
Blanch, Richard J., et al.. (2019). Detection of Papilloedema Study (DOPS): rates of false positive papilloedema in the community. Eye. 33(7). 1073–1080. 14 indexed citations
3.
Mollan, Susan P., Brendan Davies, N. C. Silver, et al.. (2018). Idiopathic intracranial hypertension: consensus guidelines on management. Journal of Neurology Neurosurgery & Psychiatry. 89(10). 1088–1100. 332 indexed citations breakdown →
4.
Yusuf, Imran H., Barny Foot, James Galloway, et al.. (2018). The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary. Eye. 32(7). 1168–1173. 48 indexed citations
6.
Barry, John A., Susan P. Mollan, Michael Burdon, Michelle Jenkins, & Alastair K. Denniston. (2017). Development and validation of a questionnaire assessing the quality of life impact of Colour Blindness (CBQoL). BMC Ophthalmology. 17(1). 179–179. 24 indexed citations
7.
Rauz, Saaeha, B Foot, Stephen B. Kaye, et al.. (2017). The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: executive summary. Eye. 32(1). 44–48. 6 indexed citations
8.
Sinclair, Alexandra J., Michael Burdon, Peter Nightingale, et al.. (2012). Rating papilloedema: an evaluation of the Frisén classification in idiopathic intracranial hypertension. Journal of Neurology. 259(7). 1406–1412. 67 indexed citations
9.
Sinclair, Alexandra J., et al.. (2011). Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia. 31(16). 1627–1633. 126 indexed citations
10.
Sinclair, Alexandra J., Michael Burdon, Peter Nightingale, et al.. (2010). Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 341(jul07 2). c2701–c2701. 233 indexed citations
11.
Howman, Andrew, Keith Wheatley, Michael Burdon, et al.. (2010). A randomised controlled trial of treatment for idiopathic intracranial hypertension. Journal of Neurology. 258(5). 874–881. 106 indexed citations
12.
Sinclair, Alexandra J., Mark R. Viant, Michael Burdon, et al.. (2009). NMR‐based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases – a diagnostic tool?. NMR in Biomedicine. 23(2). 123–132. 104 indexed citations
13.
Mollan, Susan P., Alexandra J. Sinclair, Carl E Clarke, et al.. (2009). Idiopathic Intracranial Hypertension Associated with Iron Deficiency Anaemia: A Lesson for Management. European Neurology. 62(2). 105–108. 45 indexed citations
14.
Mollan, Susan P., et al.. (2008). Aetiology and outcomes of adult superior oblique palsies: a modern series. Eye. 23(3). 640–644. 38 indexed citations
15.
Sinclair, Alexandra J., John Curnow, Jeremy Tomlinson, et al.. (2008). Elevated cerebrospinal fluid (CSF) leptin in idiopathic intracranial hypertension (IIH): evidence for hypothalamic leptin resistance?. Clinical Endocrinology. 70(6). 863–869. 57 indexed citations
16.
Sinclair, Alexandra J., Jeremy Tomlinson, Michael Burdon, et al.. (2007). A Putative Role for 11ß-Hydroxysteroid Dehydrogenase 1 in the Regulation of Human Cerebrospinal Fluid Dynamics. Investigative Ophthalmology & Visual Science. 48(13). 927–927. 1 indexed citations
17.
Burdon, Michael, et al.. (2004). Granting Emergency Interim Injunction Pending Trial in the GSK Generic Patent Litigation. Journal of Generic Medicines The Business Journal for the Generic Medicines Sector. 1(2). 167–175. 1 indexed citations
18.
Johnston, Robert L., et al.. (1999). Dominant optic atrophy. Ophthalmology. 106(1). 123–128. 36 indexed citations
19.
Burdon, Michael & M D Sanders. (1996). The retina. Current Opinion in Neurology. 9(1). 16–20.
20.
Tsaloumas, Marie, Peter Good, Michael Burdon, & Gary P. Misson. (1994). Flash and pattern visual evoked potentials in the diagnosis and monitoring of dysthyroid optic neuropathy. Eye. 8(6). 638–645. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026